Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Asymchem Laboratories Tianjin CoASLTY 72 Net Cash per Share is $1.01 as of Mar. 2026, which is 91% below its 10-year median of 11.29. GuruFocus rates ASLTY with a GF Scoreâ„¢ of 72/100 and a GF Valueâ„¢ of $4.68 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 802 Biotechnology companies, Asymchem Laboratories Tianjin Co ranks worse than 72.57% on this metric.
The historical rank and industry rank for Asymchem Laboratories Tianjin Co's Net Cash per Share or its related term are showing as below:
ASLTY'
s Price-to-Net-Cash Range Over the Past 10 Years
Min: 4.59 Med: 11.29 Max: 155.77
Current: 11.58
During the past 13 years, the highest Price-to-Net-Cash Ratio of Asymchem Laboratories Tianjin Co was 155.77. The lowest was 4.59. And the median was 11.29.
ASLTY's Price-to-Net-Cash is ranked worse than 72.57% of 802
companies
in the Biotechnology industry
Industry Median: 5.32
vs ASLTY: 11.58
Asymchem Laboratories Tianjin Co (OTCPK:ASLTY) Net Cash per Share Explanation
Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.
Asymchem Laboratories Tianjin Co Net Cash per Share Related Terms
Asymchem Laboratories Tianjin Co Net Cash per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asymchem Laboratories Tianjin Co Net Cash per Share Chart
ASLTY vs VRTX, REGN, ALNY: Net Cash per Share Comparison
For the Biotechnology subindustry, Asymchem Laboratories Tianjin Co's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asymchem Laboratories Tianjin Co Price-to-Net-Cash vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Asymchem Laboratories Tianjin Co's Price-to-Net-Cash distribution charts can be found below:
* The bar in red indicates where Asymchem Laboratories Tianjin Co's Price-to-Net-Cash falls into.
Asymchem Laboratories Tianjin Co Net Cash per Share Calculation
In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asymchem Laboratories Tianjin Co (ASLTY) has a Net Cash per Share of $1.01 as of Mar. 2026. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on Asymchem Laboratories Tianjin Co and its competitors. This is 91% below median its historical median of 11.29. Over the past decade, Asymchem Laboratories Tianjin Co's Net Cash per Share has ranged from 4.59 to 155.77. According to the industry distribution chart, Asymchem Laboratories Tianjin Co ranks #582 out of 802 companies in the Biotechnology industry, placing it in the top 72.6%.
Is Asymchem Laboratories Tianjin Co's Net Cash per Share too high?
Asymchem Laboratories Tianjin Co's current Net Cash per Share of $1.01 is 91% below median its 10-year median of 11.29. Over the past 10 years, this metric has ranged from a low of 4.59 to a high of 155.77. The Biotechnology industry median Net Cash per Share is 5.32. Asymchem Laboratories Tianjin Co's value of $1.01 is 81% below this industry median. Based on the distribution chart, Asymchem Laboratories Tianjin Co ranks #582 out of 802 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Asymchem Laboratories Tianjin Co has a GF Scoreâ„¢ of 72/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Asymchem Laboratories Tianjin Co's Net Cash per Share compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Asymchem Laboratories Tianjin Co ranks #582 out of 802 companies for Net Cash per Share. This places Asymchem Laboratories Tianjin Co in the lower half of its industry. The industry median Net Cash per Share is 5.32. Asymchem Laboratories Tianjin Co's value of $1.01 is 81% below this benchmark. Historically, Asymchem Laboratories Tianjin Co's own Net Cash per Share has ranged from 4.59 to 155.77 over the past decade. While the company's 10-year median is 11.29 vs. the industry median of 5.32, Asymchem Laboratories Tianjin Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Cash per Share for a Biotechnology company?
The median Net Cash per Share among Biotechnology companies is 5.32, based on 802 companies in the industry. Companies in the top quartile (top 25%) have a Net Cash per Share significantly above this median, while those in the bottom quartile fall well below. However, Net Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Asymchem Laboratories Tianjin Co's current Net Cash per Share of $1.01 is 81% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Cash per Share mean?
A high Net Cash per Share can signal that a stock is expensive relative to its fundamentals. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on Asymchem Laboratories Tianjin Co and its competitors. For the Biotechnology industry, the median Net Cash per Share is 5.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asymchem Laboratories Tianjin Co's current Net Cash per Share is $1.01, which is 91% below median its own 10-year median of 11.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asymchem Laboratories Tianjin Co stock overvalued right now?
Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co (ASLTY) is currently considered Significantly Overvalued. The stock's GF Value™ is $4.68, compared to a current price of $6.37 — trading 36.1% above its estimated fair value. The current Net Cash per Share is $1.01, which is 91% below median its 10-year median of 11.29 and 81% below the Biotechnology industry median of 5.32. Asymchem Laboratories Tianjin Co's overall GF Score™ is 72/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Cash per Share calculated?
Net Cash per Share is calculated from a company's financial statements. For Asymchem Laboratories Tianjin Co (ASLTY), the current Net Cash per Share is $1.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Asymchem Laboratories Tianjin Co (ASLTY) Overvalued in 2026?
Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co stock appears to be overvalued.
The current stock price of $6.37 is trading 36.1% above its estimated GF Value™ of $4.68.
GuruFocus considers Asymchem Laboratories Tianjin Co to be Significantly Overvalued.
Key valuation signals for ASLTY:
Net Cash per Share: $1.01 (91% below median its 10-year median of 11.29)
GF Value™: $4.68 vs. price of $6.37 (36.1% above fair value)
Industry Position: 81% below the Biotechnology median (#582 of 802)
No single metric tells the full story. See the ASLTY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Asymchem Laboratories Tianjin Co Business Description
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development and manufacturing organization solutions throughout the drug development and manufacturing process. The group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing, which focus on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.
72GF Score
Get the complete analysis for ASLTY
Net Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASLTY has been successfully added to your 
